Delivering the next generation of cancer immunotherapies with RNA
Cell · 2023-04 · 186 (8) · 1535-1540
DOI: 10.1016/j.cell.2023.02.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2023-04. Verfasst von Theresa M Raimondo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; David H. Koch Institute for Integrative Cancer R…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, RNA. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, U…
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
Zitieren
APA
Raimondo, T. M., Reed, K., Shi, D., Langer, R., & Anderson, D. G. (2023). Delivering the next generation of cancer immunotherapies with RNA. Cell, 186(8), 1535-1540. https://doi.org/10.1016/j.cell.2023.02.031
Vancouver
Raimondo TM, Reed K, Shi D, Langer R, Anderson DG. Delivering the next generation of cancer immunotherapies with RNA. Cell. 2023;186(8):1535-1540. doi:10.1016/j.cell.2023.02.031
BibTeX
@article{Raimondo2023,
author = {Raimondo, Theresa M and Reed, Kaelan and Shi, Dennis and Langer, Robert and Anderson, Daniel G},
title = {Delivering the next generation of cancer immunotherapies with RNA},
journal = {Cell},
year = {2023},
volume = {186},
number = {8},
pages = {1535--1540},
doi = {10.1016/j.cell.2023.02.031}
}
EUVIMED